MECHANISM OF RESISTANCE OF NONCYCLING MAMMALIAN-CELLS TO 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE - COMPARISON OF UPTAKE, METABOLISM, AND DNA BREAKAGE IN LOG-PHASE AND PLATEAU-PHASE CHINESE-HAMSTER FIBROBLAST CELL-CULTURES
- 15 January 1988
- journal article
- research article
- Vol. 48 (2) , 310-319
Abstract
Resistance of noncycling cells to amsacrine (m-AMSA) has been widely reported and may limit the activity of this drug against solid tumors. The biochemical mechanisms(s) for this resistance have been investigated using spontaneously transformed Chinese hamster fibroblasts (AA8 cells, a subline of Chinese hamster ovary cells) in log- and plateau-phase spinner cultures. In early plateau phase most cells entered a growth-arrested state with a G1-G0 DNA content and showed a marked decrease in sensitivity to cytotoxicity induced by a 1-h exposure to m-AMSA or to its solid tumor-active analogue, CI-921. Studies with radiolabeled m-AMSA established that similar levels of drugs were accumulated by log-and plateau-phase cells and that there was no significant drug metabolism in either of these cultures after 1 h. However, marked differences in sensitivity to m-AMSA-induced DNA breakage were observed using a fluorescence assay for DNA unwinding (Kanter P. M., and Schwartz, H. S., Mol. Pharmacol., 22: 145-151, 1982). Changes in sensitivity to DNA breakage occurred in parallel with changes in sensitivity to m-AMSA-induced cell killing. DNA breaks disappeared rapidly after drug removal (half-time approximately 4 min), suggesting that these lesions were probably mediated by DNA topoisomerase II. Resistance to m-AMSA may therefore be associated with changes in topoisomerase II activity in noncycling cells.This publication has 14 references indexed in Scilit:
- Formation and rejoining of deoxyribonucleic acid double-strand breaks induced in isolated cell nuclei by antineoplastic intercalating agentsBiochemistry, 1984
- Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.Journal of Biological Chemistry, 1984
- The use of human cancer cell lines as a primary screening system for antineoplastic compoundsEuropean Journal of Cancer and Clinical Oncology, 1984
- Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.Proceedings of the National Academy of Sciences, 1984
- SYNTHESIS, ANTITUMOR-ACTIVITY, AND DNA-BINDING PROPERTIES OF A NEW DERIVATIVE OF AMSACRINE, N-5-DIMETHYL-9-[(2-METHOXY-4-METHYLSULFONYLAMINO)PHENYLAMINO]-4-ACRIDINECARBOXAMIDE1984
- METABOLISM OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-META-ANISIDIDE BY RAT-LIVER MICROSOMES1984
- COMPARISON OF THE INVIVO AND INVITRO ANTILEUKEMIC ACTIVITY OF MONOSUBSTITUTED DERIVATIVES OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-META-ANISIDIDE1982
- A comparison of adriamycin and mAMSA in vitro: Cell lethality and SCE studiesBritish Journal of Cancer, 1981
- ACTIVITY OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-META-ANISIDIDE AGAINST CHINESE-HAMSTER CELLS IN MULTICELLULAR SPHEROIDS1981
- Thiolytic cleavage of the anti-tumour compound 4′-(9-acridinylamino)-methanesulphon-m-anisidine (m-AMSA, NSC 156 303) in bloodChemico-Biological Interactions, 1977